9 months ago
ASND
AnalystsAlex ThompsonAlex Thompson's Stock Forecasts
AnalystsAlex Thompson
Sectors:
Industries:
Analyst Ranking
Top 21%
#1006 out of 4986 analysts
Average Return
+8.19%
Win Rate
56%19 out of 34
Risk vs Reward
Poor
Good
Alex Thompson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dice Therapeutics IncDICE | +126.21% | $21.02 | $47.55 | 2022-09-07 - 2023-08-08 | Strong Buy |
Chinook Therapeutics IncKDNY | +110.51% | $17.99 | $37.87 | 2022-06-28 - 2023-06-13 | Strong Buy |
Immunovant IncIMVT | +108.86% | $15.47 | $32.31 | 2023-03-30 - 2024-03-28 | Strong Buy |
Spyre Therapeutics IncSYRE | +108.11% | $14.75 | $30.69 | 2023-07-25 - 2024-07-24 | Strong Buy |
Morphic Holding IncMORF | +86.81% | $29.12 | $54.40 | 2022-09-07 - 2023-08-09 | Strong Buy |
Alex Thompson Analyst Color
Get additional color on Alex Thompson's coverage of popular stocks
a year ago
ARGX
a year ago
SYRE
2 years ago
SYRE
2 years ago
ACRS
2 years ago
IMVT
3 years ago
ARGX
3 years ago
KDNY
Alex Thompson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascendis Pharma AASND | 3 | Strong Buy | $254.00 | +30.51% | Maintains | 13 days ago |
Cullinan Therapeutics IncCGEM | 1 | Strong Buy | $22.00 | +190.24% | Reinstates | 2 months ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $55.00 | +29.20% | Reinstates | 3 months ago |
Travere Therapeutics IncTVTX | 3 | Hold | $23.00 | +30.46% | Maintains | 4 months ago |
Third Harmonic Bio IncTHRD | 2 | Hold | $5.00 | -7.06% | Downgrades | 5 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $36.00 | +304.72% | Initiates Coverage On | 5 months ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Strong Buy | $60.00 | +103.87% | Initiates Coverage On | 5 months ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $49.00 | +236.54% | Initiates Coverage On | 10 months ago |
Morphic Holding IncMORF | 4 | Hold | $57.00 | N/A | Maintains | a year ago |
Argenx SeARGX | 4 | Strong Buy | $500.00 | N/A | Maintains | a year ago |
Spyre Therapeutics IncSYRE | 3 | Strong Buy | $54.00 | N/A | Reiterates | a year ago |
Dianthus Therapeutics IncDNTH | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 2 years ago |
Ventyx Biosciences IncVTYX | 5 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Strong Buy | $69.00 | N/A | Maintains | 2 years ago |
Aclaris Therapeutics IncACRS | 4 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Viridian Therapeutics IncVRDN | 2 | Strong Buy | $40.00 | N/A | Reiterates | 2 years ago |
Rapt Therapeutics IncRAPT | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 2 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $41.00 | N/A | Downgrades | 2 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 3 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.